Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharmacol Toxicol Methods ; 67(1): 50-3, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23231925

RESUMO

INTRODUCTION: Single-dose pharmacokinetics of orbifloxacin (2.5mg/kg body weight) were determined in clinically normal female Patanwadi sheep (n=6) following intravenous and intramuscular administration. METHODS: Orbifloxacin concentrations were determined by high performance liquid chromatography with ultraviolet detection. The concentration-time data were analyzed by non-compartmental kinetic method. RESULTS AND DISCUSSION: Following a single intravenous injection, an elimination half-life (t(1/2ß)) of 8.31±0.102h. Steady-state volume of distribution (Vd(ss)) and total body clearance (Cl(B)) were 3.09±0.282L/kg and 0.158±0.006L/kg/h, respectively. Following intramuscular administration, an elimination rate constant (ß), the area under the curve from zero to infinity (AUC(0-∞)) and the mean absorption time (MAT) were 0.015±0.001h(-1), 23.49±1.722µg·h/mL and 7.50±0.58h, respectively. The peak plasma concentration (C(max)) of 1.81±0.005µg/mL was achieved at 1.00±0.00h. The mean residence time (MRT) was 26.25±1.083h and the absolute bioavailability was 150.8±12.35%, respectively. Orbifloxacin could be useful for the treatment of bacterial infections in sheep that are sensitive to this drug.


Assuntos
Ciprofloxacina/análogos & derivados , Ovinos/sangue , Administração Intravenosa , Animais , Cromatografia Líquida de Alta Pressão/métodos , Ciprofloxacina/administração & dosagem , Ciprofloxacina/análise , Ciprofloxacina/sangue , Feminino , Injeções Intramusculares , Especificidade da Espécie , Espectrofotometria Ultravioleta/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...